| Literature DB >> 24530749 |
U De la Cruz-Mosso1, R Bucala2, C A Palafox-Sánchez1, I Parra-Rojas3, J R Padilla-Gutiérrez1, A L Pereira-Suárez1, H Rangel-Villalobos4, M Vázquez-Villamar1, L I Angel-Chávez1, J F Muñoz-Valle5.
Abstract
Macrophage migration inhibitory factor (MIF) is an upstream immunoregulatory cytokine associated with the pathogenesis of autoimmune inflammatory diseases. There is evidence that MIF functions in a positive feedback loop with TNF-α that could perpetuate the inflammatory process in systemic lupus erythematosus (SLE). In this case-control study we investigated whether commonly occurring functional MIF polymorphisms are associated with SLE as well as with MIF and TNF-α serum levels in a Mexican-Mestizo population. Genotyping of the -794 CATT5-8 (rs5844572) and -173 G>C (rs755622) MIF polymorphisms was performed by PCR and PCR-RFLP, respectively in 186 SLE patients and 200 healthy subjects. MIF and TNF-α serum levels were determined by ELISA. A significant increase of MIF and TNF-α levels was found in SLE patients. According to a genetic model, we found a significant association of genotypes carrying the -794 CATT7 and -173(∗)C risk alleles with susceptibility to SLE and with a significant increase of TNF-α. In conclusion, MIF gene polymorphisms are associated with SLE susceptibility and with an increase of TNF-α serum levels in a Mexican-Mestizo population.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24530749 PMCID: PMC4017948 DOI: 10.1016/j.humimm.2014.02.014
Source DB: PubMed Journal: Hum Immunol ISSN: 0198-8859 Impact factor: 2.850